Widener University Commonwealth Law School is seeking to hire two visiting professors for the 2024-25 academic year. We have strong needs in Property, Legal Methods and Contracts. Additional courses are flexible but we have additional needs in the areas of environmental law, intellectual property, wills & trusts, administrative law and other upper level courses. Interested persons should submit a cover letter and resume to Professor Robyn Meadows, Chair, Faculty Appointments Committee, at rlmeadows@widener.edu.
Open Visiting Professor Position(s) at the University of Oklahoma College of Law for Spring 2025
Dear BLPB Readers:
“University of Oklahoma College of Law is pleased to announce that it is currently seeking
applicants for visiting professor position(s) for Spring 2025 of the upcoming academic year. The
law school has a number of curricular needs, but is especially interested in candidates
specializing in bankruptcy, secured transactions, consumer law and finance, and payment
systems.”
The complete announcement is here: Download Spring 2025 Visiting Position University of Oklahoma College of Law
Trial Court Blesses Shadow Insider Trading
A federal jury found Matthew Panuwat liable for insider trading late last week. As you may recall, the U.S. Securities and Exchange Commission (SEC) brought an enforcement action against Mr. Panuwat in the U.S. District Court for the Northern District of California back in August 2021. In that legal action, the SEC alleged that Mr Panuwat violated Section 10(b) of the Securities Exchange Act of 1934, as amended, and Rule 10b-5, seeking a permanent injunction, a civil penalty, and an officer and director bar. The theory of the case, as described by the SEC in a litigation release, was founded on Mr. Panuwat’s deception of his employer, Medivation, Inc., by using information obtained through his employment to trade in the securities of another firm in the same industry.
Matthew Panuwat, the then-head of business development at Medivation, a mid-sized, oncology-focused biopharmaceutical company, purchased short-term, out-of-the-money stock options in Incyte Corporation, another mid-cap oncology-focused biopharmaceutical company, just days before the August 22, 2016 announcement that Pfizer would acquire Medivation at a significant premium. Panuwat allegedly purchased the options within minutes of learning highly confidential information concerning the merger. According to the complaint, Panuwat knew that investment bankers had cited Incyte as a comparable company in discussions with Medivation and he anticipated that the acquisition of Medivation would likely lead to an increase in Incyte’s stock price. The complaint alleges that Medivation’s insider trading policy expressly forbade Panuwat from using confidential information he acquired at Medivation to trade in the securities of any other publicly-traded company. Following the announcement of Medivation’s acquisition, Incyte’s stock price increased by approximately 8%. The complaint alleges that, by trading ahead of the announcement, Panuwat generated illicit profits of $107,066.
The SEC’s theory of liability, an application of insider trading’s misappropriation doctrine as endorsed by the U.S. Supreme Court in U.S. v. O’Hagan, has been labeled “shadow trading.”
The Director of the SEC’s Division of Enforcement, Gurbir S. Grewal, put it plainly in responding to the jury verdict in the Panuwat case on Friday:
As we’ve said all along, there was nothing novel about this matter, and the jury agreed: this was insider trading, pure and simple. Defendant used highly confidential information about an impending announcement of the acquisition of biopharmaceutical company Medivation, Inc., the company where he worked, by Pfizer Inc. to trade ahead of the news for his own enrichment. Rather than buying the securities of Medivation, however, Panuwat used his employer’s confidential information to acquire a large stake in call options of another comparable public company, Incyte Corporation, whose share price increased materially on the important news.
Yet, many assert that the SEC’s theory in Panuwat broadens the potential for SEC insider trading violations and enforcement. See, e.g., here, here, and here. They include:
- a wide class of nonpublic information that may be determined to be material and give rise to an insider trading claim;
- the expansive scope of insider trading’s requisite duty of trust and confidence (and the potential importance of language in an insider trading compliance policy or confidentiality agreement in defining that duty); and
- the potentially large number of circumstances in which employees may be exposed to confidential information about their employer that represents a value proposition in another firm’s securities.
Three of us on the BLPB have held some fascination regarding the Panuwat case over the past three years. Ann put the case on the blog’s radar screen; John later offered perspectives based on the language of Medivation’s insider trading compliance policy; and I offered comments on John’s post (and now offer this post of my own). I am thinking we all may have more to say on shadow trading as additional cases are brought or as this case further develops on appeal (should there be one). But in the interim, we at least know that one jury has agreed with the SEC’s shadow trading theory of liability.
The Business Lawyer – Call for Papers, 2024
Call for Submissions
The Business Lawyer (TBL) is currently accepting submissions for Volume 79, Summer and Fall issues to be published in 2024. TBL is the peer-reviewed scholarly law review and premier publication of the ABA Business Law Section with over 19,000 readers. The Section welcomes article submissions to TBL on topics that advance the development, understanding, and analysis of business law. The Section also welcomes submissions of scholarly articles from legal academics who are looking for a large audience for their scholarship or who wish to adapt their prior research for use by the judiciary and the practicing bar. Pioneering articles originally published in The Business Lawyer have led to significant practice developments, notably in connection with standard practices for legal opinions and audit response letters.
In addition, the Section’s Diversity, Equity and Inclusion Plan encourages a diverse set of viewpoints and backgrounds for TBL authors. The plan includes the widest range of business law practitioners including but not limited to young lawyers, law students, senior lawyers, international lawyers, lawyers of diverse or underrepresented ethnic and racial backgrounds, lawyers with disabilities, LGBTQ2+ lawyers, and women lawyers.
All submissions should be in Word format, double-spaced (including footnotes), accompanied by author contact information, resumes, and an abstract. Manuscripts, including footnotes, ordinarily should not exceed one hundred pages in length (or about 25,000 words). In general, text and footnotes should follow the style and citation format prescribed in The Bluebook: A Uniform System of Citation (21st Edition). In addition, a manuscript will not be considered, and should not be submitted, if it is under consideration for publication elsewhere.
We look forward to reviewing your manuscripts. Please submit them to The Business Lawyer’s Production Manager, Diane Babal, at diane.babal@americanbar.org. Direct any questions to diane.babal@americanbar.org or 312/988-5507.
Match is out!
It’s the moment we’ve all been waiting for and – the Delaware Supreme Court holds that all conflicted controller transactions require MFW protections to win business judgment review.
It also appears that the special committee must be composed completely of independent directors – none of this, oh, well, one turned out to be conflicted but it didn’t matter much business, which to me actually tightens the standard that I kind of assumed was being employed, and was employed in the Chancery decision in Match itself.
Also, I have previously remarked on the disjunction between requiring MFW for conflicted transactions, but only board independence for considering litigation demands against controlling shareholders. In my paper, After Corwin: Down the Controlling Shareholder Rabbit Hole, I said:
litigation demands are, in a real sense, different from ordinary conflict transactions. If directors are too conflicted to consider the merits of a transaction, the court evaluates its fairness. By contrast, if directors are too conflicted to consider the merits of bringing litigation, shareholders themselves are permitted to assume control of corporate machinery to bring the action in their stead. For that reason, demand excusal may legitimately be viewed as its own category of problem.
Reading quickly, it appears the Delaware Supreme Court adopted similar reasoning:
Admittedly, there is a tension in our law in these contexts. But Aronson and our demand review precedent stand apart from the substantive standard of review in controlling stockholder transactions. The distinction is grounded in the board’s statutory authority to control the business and affairs of the corporation, which encompasses the decision whether to pursue litigation.
(They didn’t cite me but that’s okay, they cited me for something else, I can live with it.)
I may or may not have more to say as I read again; it’s a very short opinion and doesn’t seem to address what I believe have become the real issues: who is a controlling shareholder, and what counts as a conflicted transaction? That’s really what’s created much of the difficulty, but resolution must await another day.
I guess I’ll conclude with: the Council of the Corporation Law Section of the Delaware State Bar Association may be cowed by threats of migration out of Delaware, but the Delaware Supreme Court is holding firm.
Finfluencers and the Reasonable Retail Investor
Calling attention today to Sue Guan’s paper, Finfluencers and the Reasonable Retail Investor, posted on SSRN and forthcoming to the University of Pennsylvania Law Review Online. The abstract is copied in below.
Much recent commentary has focused on the dangers of finfluencers. Finfluencers are persons or entities that have outsize impact on investor decisions through social media influence. These finfluencers increasingly drive investing and trading trends in a wide range of asset markets, from stocks to cryptocurrency. They do so because they can provide powerful coordination mechanisms across otherwise diffuse investor and trader populations. Of course, the more influence wielded over their followers, the easier it is for finfluencers to perpetrate fraud and manipulation.
The increase in finfluencing has highlighted a gray area in the securities laws: a finfluencer’s statements may not be factually untrue or clearly deceptive, but they can be interpreted as misleading depending on the context and the particular beliefs held by the finfluencer’s social media followers. Moreover, such statements can harm investors who buy or sell based on their interpretation of the finfluencer’s activity. In other words, finfluencers can easily profit off of their followers’ trading activity while steering clear of the securities laws.
A recent case has narrowed finfluencers’ ability to do so. This Piece argues that In re Bed Bath and Beyond provides a path to holding finfluencers accountable even when they have not made clearly untrue statements. In considering materiality, In re Bed Bath and Beyond focuses on the reasonable retail investor. This places primacy on retail investors’ interpretation of social media activity and narrows a gap in securities oversight, demonstrating that existing securities laws can be flexible enough to deter and punish a significant portion of problematic finfluencer behavior. In doing so, it opens a path forward for harmed retail investors to seek redress from careless finfluencers.
Sue offers a video summary here.
In this work, Sue takes on one of my favorite topics: materiality. She sees the potential for courts to use the reasonable retail investor–as opposed to the reasonable investor–as the reference point for materiality analysis in securities fraud actions. Truly interesting.
Social media does move markets. Investors, retail investors, act on what they read in social media. They may even act based on interpretations of emojis, as Sue suggests. I appreciate her taking on the legal aspects of market behavior in this context. I am confident more will be said about this as additional cases are brought.
Remembering Roberta Karmel
I learned earlier this week of the death of Brooklyn Law Professor Roberta Karmel. Roberta was extraordinary, and I miss her already. Much has been written about her role in our profession–including her service as the first female commissioner at the Securities and Exchange Commission. I will only add a few personal reflections here.
Roberta was both exacting and compassionate–traits that we sometimes think of as being mutually exclusive. Small in stature, she somehow was still formidable. When I first met her in a setting where she was commenting on academic work, I was impressed and intimidated. Despite my extroversion, I was hesitant to introduce myself and reach out to her in friendship. When I later admitted that to her, she laughed and (in that inimitable voice we all know and will remember) let me know how silly that was.
Roberta was the honored keynote speaker at our 2009 law graduation (hooding) ceremony at The University of Tennessee College of Law. She was invited by a student committee that understood well her significance to the law and legal education communities. She shared details of her life and career with us. It was inspirational for me, even though I knew parts of the story. Hearing that history in her own voice was priceless.
I was blessed to be part of a symposium held back in May 2021 to honor Roberta’s career. My paper from that symposium reflects on and extends an earlier published piece of her work. I offered a post on that paper here. As I note in that post, having the opportunity to review and dissect Roberta’s work helped me in my own.
Thinking about all of this today does make me sad. Roberta’s wisdom and voice will no longer add new ideas to the mix. However, there also is cause for gratitude and hope. She has left a strong legacy–one that we all can continue to reflect on and use in our work for many years to come.
What is the value of the corporate form?
The Tulane Corporate Law Institute this year was unusually contentious, and that’s because a lot of corporate practitioners – defense side – were unhappy with a number of recent Delaware decisions.
Tornetta v. Musk made headlines because of the colorful personalities involved, but it actually rested on fairly commonplace, well-established Delaware standards of review. More unsettling, I think, from the corporate bar’s perspective, were decisions like Sjunde AP-Fonden v. Activision Blizzard (which I blogged about here), Crispo v. Musk (which I blogged about here), and West Palm Beach Firefighters’ Pension Fund v. Moelis & Co. (which I blogged about here), because those cases upset settled expectations of practitioners. (VC Laster obliquely referred to some of the complaints in his decision denying interlocutory review in TripAdvisor: “Rule 42 does not invite a trial court to consider the level of media attention that a decision has received. That does not mean that the Delaware Supreme Court could not consider it. The justices might conclude that given the media attention and practitioner-driven stormlets over Delaware’s place in the corporate universe, Delaware’s highest court should weigh in. But that is not a consideration that Rule 42 instructs a trial court to take into account.”)
So it was in some sense unsurprising to see the Council of the Corporation Law Section of the Delaware State Bar Association immediately propose some legislative fixes.
Now, with the caveat that these proposals were just released, and I read them quickly, so I reserve the right to be totally wrong in my interpretation/analysis –
For Crispo, the proposal would make it possible for merger partners to specify that lost premium damages are available in the event of a broken deal, and further allow the target to create a shareholder’s representative who can seek lost premium damages on shareholders’ behalf (which, as I blogged, is something companies have sought to arrange through private ordering).
For Activision, the proposal allows boards to approve “substantially final” versions of merger agreements, especially if key terms are not included in the agreement but otherwise available to the board, and that disclosure schedules are not considered to be part of the merger agreement subject to board approval.
I don’t find either of these particularly controversial (though I can imagine classroom hypos that have fun with how far a disclosure schedule can go; it doesn’t strike me as a particularly precise term). As I previously blogged, in Activision, the violation seemed rather technical in nature, and Crispo just seemed like there was a divergence between the formal requirements of common law contract doctrine and the purposes a merger contract is meant to serve.
It’s the Moelis amendment that’s a bit more striking. Proposed DGCL §122(18) would allow corporations to:
Make contracts with one or more current or prospective stockholders (or one or more beneficial owners of stock), in its or their capacity as such, in exchange for such minimum consideration as determined by the board of directors (which may include inducing stockholders or beneficial owners of stock to take, or refrain from taking, one or more actions). Without limiting the provisions that may be included in such contracts, the corporation may agree to: (a) restrict or prohibit itself from taking actions specified in the contract, whether or not the taking of such action would require approval of the board of directors under this title, (b) require the approval or consent of one or more persons or bodies before the corporation may take actions specified in the contract (which persons or bodies may include the board of directors or one or more current or future directors, stockholders or beneficial owners of stock of the corporation), and (c) covenant that the corporation or one or more persons or bodies will take, or refrain from taking, actions specified in the contract (which persons or bodies may include the board of directors or one or more current or future directors, stockholders or beneficial owners of stock of the corporation). With respect to all contracts made under this subsection, the corporation shall be subject to the remedies available under the law governing the contract, including for any failure to perform or comply with its agreements under such contract.
In conjunction with this amendment, there’s a new change to DGCL §122(5), as underlined:
Appoint such officers and agents as the business of the corporation requires and to pay or otherwise provide for them suitable compensation; provided that any contract or other appointment or delegation of authority that empowers an officer or agent to act on behalf of the corporation shall be subject to § 141(a) of this title, to the extent it is applicable.
According to the Richards, Layton & Finger memo on the proposed changes, Moelis only held that contractual restrictions on the board’s authority must be contained in preferred shares rather than a separate contract; therefore, these amendments to the DGCL would not substantively affect the extent to which the board can contract out its authority. Rather, they only have the effect of allowing boards to use ordinary contracts, rather than preferred shares, to make those arrangements.
I am not sure that is an accurate interpretation of Moelis. VC Laster seemed to leave open the question how far a preferred share issuance could restrict board authority; in footnote 19, he wrote:
Moelis may not be able to get everything he wanted. Even a charter provision cannot override a mandatory feature of the DGCL….This court has indicated that some restrictions on board action could be invalid even if they appear in the charter….Some transactions, like mergers, require a specific sequence of events in which the board initiates action, then the stockholders vote. It is unclear whether a charter provision could require a stockholder’s pre-approval, before the board could act….Regardless, those issues are for another day….
So as I read it, Moelis actually touched upon a couple of different issues. The first was, how much can corporate governance be privately ordered in a personal contract/stockholder agreement, rather than in a corporate charter (including preferred share classes)? The second was, what are the fundamentally nondelegable functions of a corporate board, that cannot be restricted at all?
These are both unsettled questions because, usually, if you want that much tailoring, you either form a close corporation or – more likely these days – an LLC.
But proposed Section 122(18) blows past all that – not only does it allow for stockholder agreements to contain the kinds of governance rights previously associated with preferred shares, but it also does not seem to place any limits on the kinds of rights that can be given to stockholders directly in the first place.
We could ask why it matters whether a restriction appears in a stockholder agreement rather than a preferred share issuance. The most obvious is, if it’s a private company, the stockholder agreement may not be known to the public or even other investors. And even in a public company, stockholder agreements may be more easily amended than preferred share terms (though I imagine at least some of that difference could be mitigated with careful drafting regarding procedures for amendment of the preferreds).
But I think the broader question is the more interesting one: how much authority must a Delaware corporate board retain? Or, where is the actual line between a corporation and an LLC? Or, more generally, whether Delaware is going to be so firmly committed to private ordering in the corporate context that it functionally eliminates the distinction between the two.
And that just begs the question whether we really do need the two forms, or whether instead we should just have “the firm” which is a set of defaults that can be altered by the parties.
(Yes, yes, I know LLCs are taxed differently than corporations, but that’s an IRS choice. It can decide separately which governance arrangements stray so far into the LLC territory that the firm should be taxed like an LLC. Certainly, I don’t see any reason the label – and not the actual governance arrangements – should drive the taxation determination.)
One major argument in favor of keeping the corporate form “pure” is network benefits. It’s easier for investors when there’s a basic governance arrangement that’s stable across firms, and that way they can focus on analyzing the substantive nature of the business when making investment decisions. Writing in 2013, Michael Klausner pointed out that IPO charters demonstrate very little customization, which he took as evidence of the value of these network effects.
I genuinely wonder if that same result would be found today. Increasingly, companies are going public with shareholder agreements, byzantine multiple-class share structures, forum selection clauses, corporate opportunity waivers – and that doesn’t even count all the private companies with impenetrably complex governance and cash flow rights.
Does that suggest the network effects of the corporate form are overstated? That’s the challenge that the proposed Section 122(18) poses.
And of course it goes further. I have written about (and written about) the unsettled definition of what it means to be a controlling stockholder; allowing shareholders complete freedom to take on these kinds of governance powers demands a determination of when the powers are so overweening that the shareholder becomes a fiduciary. Unless we want to make fiduciary obligations in this context waivable as well – which again brings the corporate form closer to the LLC.
One of the odder things about the proposed legislation is that the amendments to DGCL §122(5) recognize there must be some inherent powers in the board, that cannot be delegated to someone acting on the company’s behalf – like an officer. This, presumably, is how you reconcile proposed §122(5) with proposed §122(18) – a stockholder, exercising rights under an agreement, is not acting on the corporation’s behalf, and therefore the §141(a) limits do not apply.
But think about the situation in Moelis itself. There, the stockholder was Ken Moelis, who was also CEO, and also Chair of the Board. He certainly, by virtue of the stockholder agreement, was a controlling shareholder. If he exercised his rights under the agreement, would he be acting in his private capacity, or on behalf of the company? And if on behalf of the company, does that mean §122(5) would kick in, preventing the board from delegating away its §141(a) power? I’m very confused.
Also, by the way, there’s the bit about remedies. The Richards, Layton & Finger memo on the proposed changes has this curious comment:
While the plain language of the new subsection would appear to give the board the power to bind the corporation to take fundamental action, such as approving a merger, at the direction of a stockholder, the real-world operation of any provision included in a stockholders’ agreement will be much more limited. Although an agreement adopted pursuant to new Section 122(18) may require a corporation to cause fundamental action to be taken, nothing in the statute expressly provides that individual directors may be parties to the agreement and expressly bound thereto in their directorial capacities. For example, fashioning a remedy for a corporation’s failure to cause a merger to occur as required by a stockholders’ agreement due to the failure of stockholders to adopt the merger agreement likely would involve consideration of the principles of preclusion and coercion applicable to termination fees. While new Section 122(18) recognizes that a stockholder may receive damages if the corporation fails to cause a contractually specified event to occur, the amount of any such damages will be constrained, in most cases involving fundamental corporate actions, by equitable principles. For example, fashioning a remedy for a corporation’s failure to cause a merger to occur as required by a stockholders’ agreement due to the failure of stockholders to adopt the merger agreement likely would involve consideration of the principles of preclusion and coercion applicable to termination fees.
Actually, the amendment says that any remedies may be available under the law governing the contract. Nothing in that language would prohibit equitable remedies where available, like specific performance, and courts enforce specific performance obligations against corporations all the time, including where board action (like completing a merger) is required. I agree that matters requiring a stockholder vote will still require one, but the drafting of 122(18) does not on its face prohibit an order requiring the board perform its own obligations under the agreement.
Instead, the synopsis to proposed 122(18) says:
New § 122(18) does not authorize a corporation to enter into contracts with stockholders or beneficial owners of stock that impose remedies or other consequences against directors if they take, or fail to take, specified actions as required by the contract or that purport to bind the board of directors or individual directors as parties to the contract. Contracts that would impose such remedies or consequences on directors or that would bind directors as parties are subject to existing law. Abercrombie v. Davies, 123 A.2d 893 (Del. Ch. 1956); Chapin v. Benwood Foundation, Inc., 402 A.2d 1205 (Del. Ch. 1979). Instead, new §122(18) authorizes contracts that impose remedies only against the corporation, including as a result of any failure by the corporation, its board of directors, or its current or future directors, stockholders or beneficial owners of stock, to take, or refrain from taking, actions specified in the contract. If an action addressed in a covenant by the corporation requires director or stockholder approval under title 8, that approval must still be obtained in order to effect the action pursuant to title 8. For example, the lack of stockholder approval of an action under title 8 requiring such approval would render specific performance of the covenant unavailable. Moreover, as noted below, even the enforceability of a claim for money damages for breach of the covenant may be subject to equitable review if the making or performance of the contract constitutes a breach of fiduciary duty.
Notice how this says specific performance is not available if stockholder approval is required but lacking? It conspicuously does not say specific performance is unavailable if only board action is required. So I am not at all certain how the remedies section of the proposed law squares with the claim that it would not change existing cases like Abercrombie, which holds that stockholder agreements may not significantly limit the ability of directors to exercise their judgment on matters of corporate policy.
I’ll go further – I keep beating this drum about choice of law (wrote a whole paper about it). Stockholder agreements are subject to ordinary choice of law principles, and proposed §122(18)’s reference to “the law governing the contract” apparently plans to keep it that way. Which means, we get the possibility of a California law, or Texas law, or whatever other state law, determination of whether specific performance is required. That sounds … very coherent.
Anyway, the Delaware Supreme Court has increasingly insisted that corporations are just contracts so now we’re really reaching put up or shut up time. Is there anything left for the corporate form to do? Or should we all just be teaching the law of the firm?
Search for the Executive Director Lowell Milken Institute for Business Law and Policy–UCLA, School of Law
The Lowell Milken Institute for Business Law and Policy at the University of California, Los Angeles School of Law seeks an experienced, innovative, and collaborative leader to serve as its next Executive Director. The full posting can be found here.
Thursday April 4 – ABA Banking Law Committee’s New Members Subcommittee Program on the Business of Banking and Banking Law Careers
Dear BLPB Readers:
On April 4, 2024, at 11:30am EST, the American Bar Association’s Banking Law Committee’s New Members Subcommittee will host “A 30-minute in-person and zoom meeting of the Banking Law Committee’s New Members Subcommittee” to discuss the business of banking and careers in banking law. It’s a free program for ABA members and ABA membership is free for law students! Here is a flyer with complete details: Download Promo for April 4 ABA session on banking law and careers